Breakthrough research and investor enthusiasm prompted Cullinan Therapeutics to redirect one of its cancer programs toward ...

In a report released today, Robert Driscoll from Wedbush maintained a Buy rating on Kura Oncology (KURA – Research Report), with a price target ...

Investing.com - Cullinan Oncology LLC (NASDAQ: CGEM) reported second quarter EPS of $-0.69, $0.28 better than the analyst estimate of $-0.97. Revenue for the quarter came in at ...

Roy B. Cullinan, Jr., 90, died Saturday, February 1st in CareOne at Millbury. He leaves his wife of 32 years, Gale A. (Courtney) Cullinan, three sons; Roy "Bud" Cullinan, III and his wife Carol of ...

Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer? The following represents disclosure ...

As cancer rates in the West, and globally, tack upwards due to lifestyle and environmental pollution, so does the need for ...

Wedbush analyst Robert Driscoll raised the firm’s price target on Kura Oncology (KURA) to $36 from $34 and keeps an Outperform rating on the shares. The company announced the KOMET-001 Phase 2 ...

Chairman and CEO of Citius Pharma and Citius Oncology. J-codes are unique identifiers utilized by U.S. government and commercial payers, as well as physicians and their office staff, to streamline ...

Over the last two weeks, Purdue basketball has raised more than $40,000 to fund cancer research, with the annual Hammer Down Cancer Game bringing in $35,000. The Purdue men's basketball team ...

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term mortality rates among people with advanced cancer, according to results of ...

Oncology is the branch of medicine that deals with the diagnosis and treatment of cancer. It includes medical oncology (the use of chemotherapy, hormone therapy, and other drugs to treat cancer ...